(Q36687349)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

0 references

1 reference

title

Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Lee-Jen Wei

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Dong Xu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Bruce Kreter

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

35-49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

Meta-analysis in clinical research

23 December 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00044011-200727010-00003

Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00044011-200727010-00003

Meta-analysis: neither quick nor easy

21 January 2018

1 reference

12 December 2020

Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients

1 reference

12 December 2020

A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection

1 reference

12 December 2020

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

12 December 2020

A comparison of statistical methods for meta-analysis

1 reference

12 December 2020

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

1 reference

12 December 2020

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

1 reference

12 December 2020

Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy.

1 reference

12 December 2020

Entecavir: a potent new antiviral drug for hepatitis B.

1 reference

12 December 2020

Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B

1 reference

12 December 2020

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update

1 reference

12 December 2020

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

1 reference

12 December 2020

Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype C.

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

1 reference

12 December 2020

One Year of Lamivudine Therapy ??? for Portuguese Patients with ??? Chronic Hepatitis B

1 reference

12 December 2020

Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study

1 reference

12 December 2020

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

12 December 2020

Management of hepatitis B in China

1 reference

12 December 2020

Long-term therapy of chronic hepatitis B with lamivudine.

1 reference

12 December 2020

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

1 reference

12 December 2020

Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B.

1 reference

12 December 2020

Two years of lamivudine therapy in anti-HBe-positive patients with chronic hepatitis B.

1 reference

12 December 2020

Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature

1 reference

12 December 2020

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

12 December 2020

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

12 December 2020

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.

1 reference

12 December 2020

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection

1 reference

12 December 2020

Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial

1 reference

12 December 2020

Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro

1 reference

12 December 2020

Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long-term lamivudine therapy for hepatitis B e antigen-positive chronic hepatitis B.

1 reference

12 December 2020

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

12 December 2020

Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B

1 reference

12 December 2020

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus

1 reference

12 December 2020

Meta-analyses of randomized controlled trials.

1 reference

12 December 2020

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

1 reference

12 December 2020

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

1 reference

12 December 2020

10.2165/00044011-200727010-00003

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177578%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference